March 2018

A special joint project between art and engineering has created life – at first glance, anyway. Pathos is developing tools that give art a soul. The latest works created using Pathos technology will be on show at this year’s Art Basel Hong Kong.

The two ETH particle physicists Jannis Fischer and Max Ahnen are building a brain scanner that is ten times less expensive and much smaller than current models. Their ground-breaking work has earned them a place on the 2018 "30 Under 30" list published by the American business magazine Forbes.

ETH researchers have developed a method to examine millions of potential self-produced drug candidates in one go.

Renate Schubert thinks about how to approach students’ digitalised data – and sees a lot of potential, but also some open questions.

Many school pupils fail at physics because they misunderstand the fundamental concepts. A new teaching method can change this – ETH researchers have now proven its effect. It particularly helps intelligent girls to learn more effectively.

Effy Vayena, Professor of Bioethics, explains why it’s so important to handle personal data fairly, responsibly and transparently in personalised medicine.

This Friday, two major national initiatives for personalised medicine are launched: Personalized Health Network (SPHN) and Personalized Health and Related Technologies (PHRT). Proteomics pioneer Rudolf Aebersold, metabolism researcher Markus Stoffel and ETH Vice President Detlef Günther discuss the future developments in this field.

ETH Zurich researchers have developed multifunctional origami structures, which they then fabricated into 3D printed objects. The design principle mimics the structure of an earwig’s wing.

Researchers from ETH Zurich are using a new method for digital timber construction in a real project for the first time. The load-bearing timber modules, which are prefabricated by robots, will be assembled on the top two floors at the DFAB HOUSE construction site.

A research team led by microbiologist Tomas de Wouters has won the Spark Award 2018 for the development of artificial intestinal flora. With their ETH spin-off Pharmabiome, the scientists want to further develop their invention so that it can be used in the treatment of inflammatory intestinal diseases and infections.